Next Article in Journal
Enantiopure Derivatives of Aza-Baylis-Hillman Adducts by Subsequent SN′-SN′ Reactions of Acylcarbamates Bearing a Chiral Auxiliary
Next Article in Special Issue
Structural Characterization of Calcium Alginate Matrices by Means of Mechanical and Release Tests
Previous Article in Journal
Synthesis and Olfactory Evaluation of Bulky Moiety-Modified Analogues to the Sandalwood Odorant Polysantol®
Previous Article in Special Issue
Influence of Different Polymer Types on the Overall Release Mechanism in Hydrophilic Matrix Tablets
Molecules 2009, 14(8), 2801-2823; doi:10.3390/molecules14082801
Review

Nano and Microtechnologies for the Delivery of Oligonucleotides with Gene Silencing Properties

*  and
Dipartimento di Chimica Farmaceutica e Tossicologica, Facoltà di Farmacia, Università degli Studi di Napoli Federico II, Via D. Montesano 49, 80131 Naples, Italy
* Author to whom correspondence should be addressed.
Received: 30 June 2009 / Revised: 22 July 2009 / Accepted: 27 July 2009 / Published: 29 July 2009
(This article belongs to the Special Issue Macromolecules Applied to Pharmaceutics)
Download PDF [538 KB, uploaded 18 June 2014]

Abstract

Oligonucleotides (ONs) are synthetic fragments of nucleic acid designed to modulate the expression of target proteins. DNA-based ONs (antisense, antigene, aptamer or decoy) and more recently a new class of RNA-based ONs, the small interfering RNAs (siRNAs), have gained great attention for the treatment of different disease states, such as viral infections, inflammation, diabetes, and cancer. However, the development of therapeutic strategies based on ONs is hampered by their low bioavailability, poor intracellular uptake and rapid degradation in biological fluids. The use of a non-viral carrier can be a powerful tool to overcome these drawbacks. Lipid or polymer-based nanotechnologies can improve biological stability and cellular uptake of ONs, with possibility of tissue and/or cellular targeting. The use of polymeric devices can also produce a prolonged release of the ON, thus reducing the need of frequent administrations. This review summarizes advantages and issues related to the main non-viral vectors used for ON delivery.
Keywords: oligonucleotide; siRNA; cationic liposomes; cationic polymers; PLGA microspheres oligonucleotide; siRNA; cationic liposomes; cationic polymers; PLGA microspheres
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Export to BibTeX |
EndNote


MDPI and ACS Style

De Rosa, G.; La Rotonda, M.I. Nano and Microtechnologies for the Delivery of Oligonucleotides with Gene Silencing Properties. Molecules 2009, 14, 2801-2823.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert